Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

VCA Graft Rejection & Immunosuppression Biomarker Analysis

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract, titled VCA Graft Rejection and Immunosuppression Biomarker Analysis, is issued by the Department of the Army USAMRRA under the Department of Defense. The project focuses on the identification and validation of prognostic or diagnostic biomarkers for prime contractors supporting Defense Health Agency research. The primary scope of work involves analyzing human clinical samples to monitor immunosuppression levels and VCA graft rejection through the use of high-sensitivity assay equipment. To ensure compliance with human subject research standards, the contractor must maintain CLIA certification and obtain IRB approval. The expected deliverables include technical reports, assay results, and validated biomarker profiles. The contract is categorized under NAICS code 621511 and was posted on May 29, 2026.

General Info

USAMRRA subcontract for analyzing biomarkers to monitor VCA graft rejection and immunosuppression.

Agency

Department Of Defense → Department Of The Army -- UsamraaView Agency

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of HT942526RTRPCA.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DoW Reconstructive Transplant, Concept Award

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Department Of The Army -- Usamraa
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Department Of The Army -- Usamraa
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs identification and validation of prognostic or diagnostic biomarkers for prime contractors on Defense Health Agency (DHACA) research projects. Analyzes human clinical samples to monitor VCA graft rejection and immunosuppression levels using high-sensitivity assay equipment. Requires CLIA certification and IRB approval for human subject research. Delivers validated biomarker profiles, assay results, and technical reports.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Department Of The Army -- Usamraa

Same awarding agency

NAICS: 518210
Grant
Data Management and Research Sharing Plan DevelopmentThe contract seeks the design and implementation of a secure, compliant data management plan tailored for biomedical research, with a strong emphasis on preserving data integrity, adhering to FAIR principles—findable, accessible, interoperable, and reusable—and meeting federal requirements for data sharing. The plan must ensure that all research data is handled in a manner that supports long-term preservation, ethical use, and regulatory compliance, particularly under Department of Defense standards. The subcontractor will be responsible for developing structured policies and technical workflows that align with evolving federal mandates, enabling seamless data sharing while maintaining rigorous security protocols to protect sensitive biomedical information. The initiative is managed by the Department of the Army through USAMRAA under the broader Department of Defense, with the NAICS code 518210 indicating its focus on data processing and hosting services. The opportunity is open as a subcontract, with responses due by November 4, 2026. While the physical place of performance and point of contact are not specified, the work must be executed to meet federal compliance timelines and deliverables without reliance on proprietary or non-standard frameworks. The goal is to establish a scalable, audit-ready data infrastructure that supports ongoing and future biomedical research initiatives under federal oversight.
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

3 months ago

DEADLINE

in about 2 months
View Details
NAICS: 541715
Grant
DoW Reconstructive Transplant, Concept Award
Solicitation # HT942526RTRPCA
The fiscal year 2026 Reconstructive Transplant Research Program Concept Award, funding opportunity HT942526RTRPCA, is administered by the Defense Health Agency Contracting Activity to support highly innovative new concepts or untested theories in reconstructive transplantation. This grant program specifically targets creative research that introduces new paradigms or examines existing problems from new perspectives, explicitly excluding clinical trials and incremental advances on published data. Projects must align with at least one FY26 RTRP Focus Area. While preliminary data is not permitted, applicants must provide a strong rationale and demonstrate the ability to achieve interpretable results. Early-career investigators at or above the postdoctoral fellow level are encouraged to apply. The program provides funding capped at 200,000 dollars per award for a maximum period of performance of 18 months, with an estimated total program appropriation of 12 million dollars for FY26. Applications are evaluated through a two-tier process consisting of a peer review for technical merit and a programmatic review for relevance to military health and RTRP priorities. Key submission requirements include a three-page Statement of Work, a one-page Innovation Statement, and a Post-Award Transition Plan. Applicants must maintain active registrations in SAM.gov, eBRAP.org, and Grants.gov. Full applications are due by September 16, 2026, and must adhere to strict PDF naming conventions and disclosure requirements regarding foreign affiliations and regulatory compliance for human or animal subjects.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 months ago

DEADLINE

in 10 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS